Home Page - 2026 National Rare Hematology Summit, Cleveland

The 2026 National Rare Hematology Summit, Cleveland aims to enhance participants' knowledge and competence in diagnosing, managing, and treating rare and complex hematologic conditions often underrepresented in mainstream conferences. Through case-based discussions, expert-led sessions, and interactive panel debates, the summit will address key challenges and recent advances in clonal hematopoiesis (CHIP), Castleman disease, hypereosinophilic syndrome (HES), mastocytosis, uncommon lymphoid malignancies, rare bleeding and platelet disorders, hemophagocytic lymphohistiocytosis (HLH), AL amyloidosis, POEMS syndrome, and nonsecretory myeloma. A dedicated focus on health disparities, multidisciplinary care models, and future directions in genomics and AI will equip attendees with actionable strategies to improve patient outcomes. Designed for a multidisciplinary audience of hematologists, medical oncologists, hematopathologists, fellows, advanced practice providers, pharmacists, nurses, clinical researchers, and industry professionals, the conference emphasizes evidence-based approaches, real-world solutions, and patient-centered care. Participants will gain practical diagnostic and therapeutic insights to navigate clinical uncertainty, leverage emerging therapies, and stay informed on the latest developments in rare hematologic malignancies and benign hematology.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

Crowne Plaza Cleveland at Playhouse Square by IHG